Nobelpharma Co., Ltd.

Nobelpharma is a Japanese pharmaceutical company founded in 2003 that specializes in the development and commercialization of drugs and medical devices for unmet medical needs, with a primary focus on rare diseases. The company employs a unique business model that avoids early-stage basic research, instead focusing on in-licensing late-stage clinical candidates and collaborating with academia and other companies to accelerate development and regulatory approval. Headquartered in Tokyo, the company has established a global presence, including Nobelpharma America LLC, to support its mission of delivering essential medicines that are often neglected by larger pharmaceutical firms. Their portfolio includes orphan drugs and treatments for conditions such as tuberous sclerosis, Wilson's disease, and various rare genetic disorders.